Evidence map›Paper›PMID 27372764›Full record

ArticleMethods in enzymology2016

Crystallographic Studies of Telomerase.

H Hoffman, E Skordalakes

Abstract read
In one paragraph

Article in Methods in enzymology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Structural Biology of Telomerase.Cold Spring Harbor perspectives in biology · 2019
    Review
  2. Telomere Maintenance in Pediatric Cancer.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

H HoffmanThe Wistar Institute, Philadelphia, PA, United States.
E SkordalakesThe Wistar Institute, Philadelphia, PA, United States. Electronic address: skorda@wistar.org.

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Targeting telomerase for melanoma therapeuticsR01CA201312 · NCI · WISTAR INSTITUTE · PI SKORDALAKES, EMMANUEL · 2016 to 2020
$2.4M
Structural and Biochemical Analysis of Telomerase FunctionR01GM088332 · NIGMS · WISTAR INSTITUTE · PI SKORDALAKES, EMMANUEL · 2010 to 2014
$1.7M
NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA201312NIGMS NIH HHS R01 GM088332
6 · The paper itself

Abstract

Telomeres are nucleoprotein complexes that maintain the ends of our chromosomes thus providing genomic stability. Telomerase is a ribonucleoprotein reverse transcriptase that replicates the short tandem repeats of DNA known as telomeres. The telomeric DNA is specifically associated with two major complexes, the shelterin and CST complexes both of which are involved in telomere length regulation and maintenance along with telomerase. Obtaining structural information on these nucleoprotein complexes has been a major bottleneck in fully understanding the mechanism of action of telomeric nucleoproteins for over two decades. The recent advances in molecular and structural biology have enabled us to obtain atomic resolution structures of telomeric proteins alone and in complex with their nucleic acid substrates transforming the field and our understanding and interpretation of this unique biological pathway. Here we report our approach to obtain the structure of the Triobolium castaneum catalytic subunit of telomerase TERT (tcTERT) in its apo- and substrate-bound states.

Indexed as

AnimalsCatalytic DomainCrystallography, X-RayDNAEnzyme AssaysHumansModels, MolecularProtein ConformationRNATelomeraseTriboliumDNARNATelomeraseCancerReverse transcriptionTelomeraseTelomeres

Identifiers

PMID27372764
PMCPMC5180420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.